Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1389576
PUBLISHER: BCC Research | PRODUCT CODE: 1389576
Global Market for Anti-obesity Drugs
PUBLISHED:
PAGES: 67 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Highlights:
This report provides an overview of the global market on anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection. The report details the anti-obesity drugs market based on drug type, distribution channel, and region.
Report Scope:
The report's scope includes an overview of the global market for anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.
The report analyzes anti-obesity drugs by drug types, assesses distribution channels, and provides an overview regarding product pipeline of major players in market. Leading market players' profiles, marketed products, pipeline products, and recent market activities are provided. The report details market for anti-obesity drugs based on drug type, distribution channel, and region. Based on drug type, the market is segmented into prescription drugs, and over-the-counter (OTC) drugs. The market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies on the basis of distribution channel. Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).
Report Includes:
- An overview of the current and future global markets for anti-obesity drugs
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the actual market size and revenue forecast for the global anti-obesity drugs market, and corresponding market share analysis based on drug type, distribution channel, and region
- Overview of ESG outlook with emphasis on sustainability trends and factors on anti-obesity drugs market
- Identification of the major vendors in the global market for anti-obesity drugs, along with an analysis of the structure of this industry, including company market shares, M&A deals and venture fundings
- Profiles of the leading global players
Product Code: PHM281A
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Research Methodology
- Information Sources
- Geographic Breakdown
- Segmentation Breakdown
Chapter 2 Summary and Highlights
- Market Outlook
- Market Summary
Chapter 3 Market Overview
- Definitions of Adult Obesity and Overweight
- Overweight- and Obesity-Related Diseases
- Rising Prevalence of Obesity
- Impact of Obesity on Global Economy
- Increasing Awareness Regarding Obesity
- SWOT Analysis
- Strengths
- Weaknesses
- Opportunities
- Threats
Chapter 4 Global Market for Anti-obesity Drugs by Type
- Prescription Drugs
- Over-the-Counter Anti-obesity Drugs
Chapter 5 Global Market for Anti-obesity Drugs by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Chapter 6 Global Market for Anti-obesity Drugs by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 ESG Developments
- Introduction to ESG
- Importance of ESG in Anti-obesity Drugs Industry
- ESG Pillars in the Anti-obesity Drug Industry
- Environmental Metrics
- Social Metrics
- Governance Metrics
- ESG Ratings and Metrics: Understanding the Data
- ESG Practices in the Anti-obesity Drug Industry
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks from BCC
Chapter 8 Competitive Landscape
- Overview
- Pipeline Analysis
- Patents on Obesity Management, 2020-2023
Chapter 9 Company Profiles
- ALTIMMUNE INC.
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- CURRAX PHARMACEUTICALS LLC
- ELI LILLY AND CO.
- F. HOFFMANN-LA ROCHE AG
- GLAXOSMITHKLINE PLC
- NOVO NORDISK A/S
- PFIZER INC.
- RHYTHM PHARMACEUTICALS, INC.
- VIVUS LLC
Product Code: PHM281A
List of Tables
- Summary Table : Global Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
- Table 1 : Definitions of Adult Obesity and Overweight
- Table 2 : Number of People, Aged Over 5 Years, and Percentage of the Population With Overweight or Obesity, 2020-2035
- Table 3 : Global Obesity Trends for Children and Adolescents, Aged 5 to 19 Years, by Gender, 2020-2035
- Table 4 : Global Obesity Trends for Adults, Aged 20 Years and Above, by Gender, 2020-2035
- Table 5 : Global Economic Impact of High BMI (BMI ≥25kg/m²), 2020-2035
- Table 6 : Global Market for Anti-obesity Drugs, by Drug Type, Through 2028
- Table 7 : Difference between Prescription Drugs and Over-the-Counter Anti-obesity Drugs
- Table 8 : Approved Prescription Drugs to Treat Overweight and Obesity
- Table 9 : Global Market for Anti-obesity Prescription Drugs, by Region, Through 2028
- Table 10 : Global Market for Over-the-Counter Anti-obesity Drugs, by Region, Through 2028
- Table 11 : Global Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
- Table 12 : Global Market for Anti-obesity Drugs Sold through Hospital Pharmacies, by Region, Through 2028
- Table 13 : Global Market for Anti-obesity Drugs Sold through Retail Pharmacies, by Region, Through 2028
- Table 14 : Global Market for Anti-obesity Drugs Sold through Online Pharmacies, by Region, Through 2028
- Table 15 : Global Market for Anti-obesity Drugs, by Region, Through 2028
- Table 16 : North American Market for Anti-obesity Drugs, by Drug Type, Through 2028
- Table 17 : North American Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
- Table 18 : European Market for Anti-obesity Drugs, by Drug Type, Through 2028
- Table 19 : European Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
- Table 20 : Asia-Pacific Market for Anti-obesity Drugs, by Drug Type, Through 2028
- Table 21 : Asia-Pacific Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
- Table 22 : Rest of the World Market for Anti-obesity Drugs, by Drug Type, Through 2028
- Table 23 : Rest of the World Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
- Table 24 : ESG Ratings and Metrics
- Table 25 : Environmental Performance
- Table 26 : Social Performance
- Table 27 : Governance Performance
- Table 28 : ESG Rankings for Major Anti-obesity Drug Companies, 2023*
- Table 29 : Anti-obesity Drugs in Clinical Trials, 2023
- Table 30 : Patents on Obesity Management, 2020-2023
- Table 31 : Altimmune: Pipeline Products
- Table 32 : Altimmune: News, 2023
- Table 33 : Boehringer Ingelheim: Pipeline Products
- Table 34 : Boehringer Ingelheim: News, 2023
- Table 35 : Currax Pharmaceuticals LLC: Products
- Table 36 : Currax Pharmaceuticals LLC: News, 2022
- Table 37 : Eli Lilly: Pipeline Products
- Table 38 : Eli Lilly: News, 2023
- Table 39 : ROCHE: Products
- Table 40 : GlaxoSmithKline: Products
- Table 41 : Novo Nordisk A/S: Products
- Table 42 : Novo Nordisk A/S: Pipeline Products
- Table 43 : Novo Nordisk A/S: News, 2023
- Table 44 : Pfizer: Pipeline Products
- Table 45 : Pfizer: News, 2023
- Table 46 : Rhythm Pharmaceuticals: Products
- Table 47 : Rhythm Pharmaceuticals: Pipeline Products
- Table 48 : Rhythm Pharmaceuticals: News, 2023
- Table 49 : VIVUS LLC: Products
- Table 50 : VIVUS LLC: News, 2023
List of Figures
- Summary Figure : Global Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
- Figure 1 : Global Market for Anti-obesity Drugs: SWOT Analysis
- Figure 2 : Global Market for Anti-obesity Drugs, by Drug Type, 2021-2028
- Figure 3 : Global Market for Anti-obesity Prescription Drugs, by Region, 2021-2028
- Figure 4 : Global Market for Over-the-Counter Anti-obesity Drugs, by Region, 2021-2028
- Figure 5 : Global Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
- Figure 6 : Global Market for Anti-obesity Drugs Sold through Hospital Pharmacies, by Region, 2021-2028
- Figure 7 : Global Market for Anti-obesity Drugs Sold through Retail Pharmacies, by Region, 2021-2028
- Figure 8 : Global Market for Anti-obesity Drugs Sold through Online Pharmacies, by Region, 2021-2028
- Figure 9 : Global Market Shares of Anti-obesity Drugs, by Region, 2023
- Figure 10 : North American Market for Anti-obesity Drugs, by Drug Type, 2021-2028
- Figure 11 : North American Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
- Figure 12 : European Market for Anti-obesity Drugs, by Drug Type, 2021-2028
- Figure 13 : European Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
- Figure 14 : Asia-Pacific Market for Anti-obesity Drugs, by Drug Type, 2021-2028
- Figure 15 : Asia-Pacific Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
- Figure 16 : Rest of the World Market for Anti-obesity Drugs, by Drug Type, 2021-2028
- Figure 17 : Rest of the World Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.